camptothecin has been researched along with Carcinoma, Papillary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodurka, DC; Gano, J; Gershenson, DM; Kavanagh, JJ; Levenback, C; Wharton, JT; Wolf, JK | 1 |
| Ching-chiang, Y; Hsien-you, C; Kui-ming, L; Pao-hua, C; Tung, H | 1 |
1 trial(s) available for camptothecin and Carcinoma, Papillary
| Article | Year |
|---|---|
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Agents, Phytogenic; CA-125 Antigen; Camptothecin; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Irinotecan; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms | 2003 |
1 other study(ies) available for camptothecin and Carcinoma, Papillary
| Article | Year |
|---|---|
Camptothecin instillation and local injection for prevention and treatment of urinary bladder tumors--a preliminary report.
Topics: Adult; Aged; Camptothecin; Carcinoma in Situ; Carcinoma, Papillary; Female; Humans; Injections; Male; Middle Aged; Urinary Bladder Neoplasms | 1979 |